Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Mbright has signed a memorandum of understanding (MOU) with ChemPartner Pharmatech Co Ltd to develop a pharmaceutical and biotechnology (biotech) hub in Malaysia https://theedgemalaysia.com/node/713115
Meta Bright managing director Lee Chee Kiang said this project would differentiate the company from typical developments, as it involves creating a niche market with a leader in the pharmaceutical and biotech sectors. What kind of niche market??
It depends on what product they are going to develop and what type of customers they are targeting. So stay close and wait for good news from the company